Evidence map›Paper›PMID 25878616›Full record

ArticlePakistan journal of medical sciences

Detection of renal brush border membrane enzymes for evaluation of renal injury in neonatal scleredema.

Qing Ren, Yongjun Zhang, Jinying Yang, Lixia Wei, Lili Zhao, Qiaozhi Yang

Open access · goldAbstract read
In one paragraph

Article in Pakistan journal of medical sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Qing RenQing Ren, MD, Department of Pediatrics, Liaocheng People's Hospital, Liaocheng, Shandong252000, China.
Yongjun ZhangYongjun Zhang, MD, Department of Pediatrics, Liaocheng People's Hospital, Liaocheng, Shandong252000, China.
Jinying YangJinying Yang, MD, Center for Disease Control and Prevention of Liaocheng, Liaocheng, Shandong 252000, China.
Lixia WeiLixia Wei, MD, Department of Pediatrics, Liaocheng People's Hospital, Liaocheng, Shandong252000, China.
Lili ZhaoLili Zhao, MD, Department of Pediatrics, Liaocheng People's Hospital, Liaocheng, Shandong252000, China.
Qiaozhi YangQiaozhi Yang, MD, Department of Pediatrics, Liaocheng People's Hospital, Liaocheng, Shandong252000, China.
Liaocheng University · CNLiaocheng People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate renal brush border membrane enzymes in urine as an indicator for renal injury in neonatal scleredema (NS).

methodsSixty nine NS patients in our hospital were enrolled and divided into mild group and moderate/severe group. Patients were further randomly divided into therapy and control subgroups for 7 days ligustrazine administration. Urine samples were collected to detect renal brush border membrane enzymes (RBBME) by ELISA and β2-microglobulin (β2-MG) by radioimmunoassay (RIA). The results were compared with those of 30 normal neonates. Data were statistically analyzed using SPSS13.0 software.

resultsBoth RBBME and β2-MG were found to be higher in urine in NS patients than normal controls (P < 0.01). Level of RBBME increased with the severity of NS (P <0.05), while urinary β2-MG did not (P >0.05). After being treated with ligustrazine, a medicine for renal function recovery, both RBBME and β2-MG were similarly significantly decreased comparing to untreated groups (P < 0.05). 79.7% of NS patients showed abnormal RBBME while only 52.2% had an abnormal urinary β2-MG (χ (2)=11.65,P < 0.01).

conclusionRBBME was more sensitive than β2-MG in reflecting the renal injury in NS. Examination of RBBME effectively reflected the recovery of renal injury after treatment with ligustrazine.

Indexed as

LigustrazineNeonatal scleredemaRenal brush border membrane enzymeRenal injuryβ2-microglobulin

Identifiers

PMID25878616
PMCPMC4386159
OpenAlexW2316807641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.